399 related articles for article (PubMed ID: 16400342)
21. [A prospective and randomized study of two conditioning regimens in treatment of severe systemic autoimmune diseases with autologous peripheral blood stem cell transplantation].
Zhang W; Zhou DB; Zhao Y; Leng XM; Zhang JP; Jiang Y; Jiao L; Wang SJ; Duan MH; Tang FL; Shen T
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1689-92. PubMed ID: 17825150
[TBL] [Abstract][Full Text] [Related]
22. Failure to achieve a threshold dose of CD34+ CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation.
Sartor MM; Garvin F; Antonenas V; Bradstock KF; Gottlieb DJ
Bone Marrow Transplant; 2007 Nov; 40(9):851-7. PubMed ID: 17704793
[TBL] [Abstract][Full Text] [Related]
23. Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT).
Ergene U; Cağirgan S; Pehlivan M; Yilmaz M; Tombuloğlu M
Transfus Apher Sci; 2007 Feb; 36(1):23-9. PubMed ID: 17292672
[TBL] [Abstract][Full Text] [Related]
24. Prospective observational study of low thresholds for platelet transfusion in adult dengue patients.
Thomas L; Kaidomar S; Kerob-Bauchet B; Moravie V; Brouste Y; King JP; Schmitt S; Besnier F; Abel S; Mehdaoui H; Plumelle Y; Najioullah F; Fonteau C; Richard P; Césaire R; Cabié A
Transfusion; 2009 Jul; 49(7):1400-11. PubMed ID: 19320862
[TBL] [Abstract][Full Text] [Related]
25. Compliance with prophylactic platelet transfusion trigger in haematological patients.
Eikenboom JC; van Wordragen R; Brand A
Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128
[TBL] [Abstract][Full Text] [Related]
26. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
27. Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study.
Tay J; Allan D; Beattie S; Bredeson C; Fergusson D; Maze D; Sabloff M; Thavorn K; Tinmouth A
BMJ Open; 2016 Oct; 6(10):e013483. PubMed ID: 27798034
[TBL] [Abstract][Full Text] [Related]
28. [Donor peripheral stem cells infusion for the treatment of failure of platelet recovery after allogeneic hematopoietic stem cell transplantation].
Chen Y; Xu LP; Liu DH; Chen YH; Han W; Shi HX; Zhang XH; Wang JZ; Chen H; Liu KY; Huang XJ; Lu DP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):964-6. PubMed ID: 17650420
[TBL] [Abstract][Full Text] [Related]
29. Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation.
Gordon B; Tarantolo S; Ruby E; Stephens L; Lynch J; Kessinger A; Haire W
Bone Marrow Transplant; 1998 Nov; 22(10):999-1003. PubMed ID: 9849698
[TBL] [Abstract][Full Text] [Related]
30. Reticulated platelet monitoring after autologous peripheral haematopoietic progenitor cell transplantation.
Martinelli G; Merlo P; Fantasia R; Gioia F; Crovetti G
Transfus Apher Sci; 2009 Jun; 40(3):175-81. PubMed ID: 19398373
[TBL] [Abstract][Full Text] [Related]
31. Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy.
Chaoui D; Chakroun T; Robert F; Rio B; Belhocine R; Legrand O; Salanoubat C; Lecrubier C; Casadevall N; Marie JP; Elalamy I
Transfusion; 2005 May; 45(5):766-72. PubMed ID: 15847667
[TBL] [Abstract][Full Text] [Related]
32. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia.
Apelseth TO; Hervig T; Bruserud O
Blood Rev; 2011 May; 25(3):113-22. PubMed ID: 21316823
[TBL] [Abstract][Full Text] [Related]
33. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
Carreras E; Rosiñol L; Terol MJ; Alegre A; de Arriba F; García-Laraña J; Bello JL; García R; León A; Martínez R; Peñarrubia MJ; Poderós C; Ribas P; Ribera JM; San Miguel J; Bladé J; Lahuerta JJ;
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1448-54. PubMed ID: 18022574
[TBL] [Abstract][Full Text] [Related]
34. Optimizing platelet transfusion therapy.
Heal JM; Blumberg N
Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
[TBL] [Abstract][Full Text] [Related]
35. [The efficacy and safety of autologous cryopreserved platelet transfusion in management of thrombocytopenia after chemotherapy in hematological malignancy].
Liu GQ; Ding HF; Lu XJ; Xu M; Xing J; Zhao X; Han F; Shang YH
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):188-91. PubMed ID: 22781890
[TBL] [Abstract][Full Text] [Related]
36. Platelet utilization and the transfusion trigger: a prospective analysis.
Greeno E; McCullough J; Weisdorf D
Transfusion; 2007 Feb; 47(2):201-5. PubMed ID: 17302764
[TBL] [Abstract][Full Text] [Related]
37. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit.
Vamvakas EC; Hitzler WE
Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342
[TBL] [Abstract][Full Text] [Related]
38. Progenitor cell recruitment during individualized high-flow, very-large-volume apheresis for autologous transplantation improves collection efficiency.
Fontana S; Groebli R; Leibundgut K; Pabst T; Zwicky C; Taleghani BM
Transfusion; 2006 Aug; 46(8):1408-16. PubMed ID: 16934079
[TBL] [Abstract][Full Text] [Related]
39. The clinical impact of platelet refractoriness: correlation with bleeding and survival.
Kerkhoffs JL; Eikenboom JC; van de Watering LM; van Wordragen-Vlaswinkel RJ; Wijermans PW; Brand A
Transfusion; 2008 Sep; 48(9):1959-65. PubMed ID: 18564396
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]